Myeloid-derived suppressor cells: a double-edged sword? (Q37840240)

24 August 2017

1 reference

title

Myeloid-derived suppressor cells: a double-edged sword? (English)

1 reference

24 August 2017

2

Janusz Marcinkiewicz

1 reference

24 August 2017

1

Agnieszka Pastuła

1 reference

24 August 2017

publication date

12 February 2011

1 reference

International Journal of Experimental Pathology

24 August 2017

published in

1 reference

24 August 2017

volume

92

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

73-78

1 reference

Cancer immunotherapy based on killing of Salmonella-infected tumor cells

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Diabetes acceleration by cyclophosphamide in the non-obese diabetic mouse is associated with differentiation of immunosuppressive monocytes into immunostimulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Type 1 T Helper Cells Induce the Accumulation of Myeloid-Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Promotion of B cell immune responses via an alum-induced myeloid cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Subsets, expansion and activation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Functional plasticity of macrophages: reversible adaptation to changing microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Nitric oxide-induced apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Overexpressed beta-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2613.2010.00754.X

The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Tumor-targeted Salmonella as a novel anticancer vector

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081509

Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells

3 December 2018

1 reference

12 December 2020

Involvement of CD11b+ GR-1 low cells in autoimmune disorder in MRL-Fas lpr mouse

1 reference

12 December 2020

Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function

1 reference

12 December 2020

Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

1 reference

12 December 2020

TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs

1 reference

12 December 2020

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

12 December 2020

CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine

1 reference

12 December 2020

Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development

1 reference

12 December 2020

Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Inhibition of tumor cell proliferation by natural suppressor cells present in murine bone marrow

1 reference

12 December 2020

Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy

1 reference

12 December 2020

10.1111/J.1365-2613.2010.00754.X

Identifiers

DOI

1 reference

24 August 2017

0 references

1 reference